Replies to post #385273 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

There’s a COVID variant -> therefore B is needed.

A drug failed the trial -> therefore B is needed.

A treatment has side effect -> therefore B is needed.

This has been the rationale for the last 24 months.

What does this have to do with Ipix?